insights from industryDr. Ruizhi WangFounder and CEOAbselion In this interview, News Medical-Life Sciences speaks with Dr. Ruizhi Wang, Founder and CEO of Abselion, about simplifying the ...
Computational assessment identifies probe binding errors in a widely used commercial platform for spatial transcriptomics.
His-tagged proteins are central to assay development, structural biology, and drug discovery projects. Their small tag facilitates rapid construct iteration and straightforward purification. Teams ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results